Giese A, Ornek A, Kurucay M, Kilic L, Şendur S N, Münker A, Puchstein C, Lainka E, Wittkowski H, Henning B F
Medizinische Klinik I, St. Josef-Hospital Bochum, Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland,
Schmerz. 2013 Dec;27(6):605-11. doi: 10.1007/s00482-013-1367-1.
Familial Mediterranean fever (FMF) is an autoinflammatory disease characterized by bouts of fever and serositis. Morbidity caused by bouts as well as self-medication were assessed among patients of Turkish ancestry living in Germany (D) or Turkey (T) in order to evaluate current analgetic concepts from a patient's perspective.
D and T were asked about the 3 months preceding the interview.
A total of 40 D and 40 T were included; 35/40 D and 40/40 T were on colchicine. In the last 3 months, 61.3 % had ≥ 1 bout and suffered from peritonitis (87.8 %), fever (61.2 %), myalgia (45 %), pleuritis (42.8 %), arthralgia (36.7 %), and cephalgia (32.6 %). Of the patients, 65.3 % were bedridden during bouts, 61.2 % sought the attention of a physician, 53.1 % were unable to work or attend school, and 38.8 % were hospitalized. The following drugs were taken: NSAIDs (45.6 %), NSAIDs and paracetamol (42.6 %), and combinations of NSAIDs with other analgesics. NSAIDs (58.6 %) and paracetamol (20.7 %) were considered the most potent substances.
FMF inflicts substantial morbidity. Patients most commonly rely on NSAIDs and paracetamol to relieve symptoms of FMF bouts.
家族性地中海热(FMF)是一种以发热和浆膜炎发作为特征的自身炎症性疾病。为了从患者角度评估当前的镇痛观念,对居住在德国(D)或土耳其(T)的土耳其裔患者发作引起的发病率以及自我用药情况进行了评估。
询问D组和T组患者在访谈前3个月的情况。
共纳入40名D组患者和40名T组患者;40名D组患者中有35名、40名T组患者均服用秋水仙碱。在过去3个月中,61.3%的患者有≥1次发作,并患有腹膜炎(87.8%)、发热(61.2%)、肌痛(45%)、胸膜炎(42.8%)、关节痛(36.7%)和头痛(32.6%)。在发作期间,65.3%的患者卧床不起,61.2%的患者寻求医生帮助,53.1%的患者无法工作或上学,38.8%的患者住院治疗。患者服用了以下药物:非甾体抗炎药(NSAIDs,45.6%)、NSAIDs与对乙酰氨基酚(42.6%)以及NSAIDs与其他镇痛药的组合。NSAIDs(58.6%)和对乙酰氨基酚(20.7%)被认为是最有效的药物。
FMF会导致严重的发病率。患者最常依靠NSAIDs和对乙酰氨基酚来缓解FMF发作的症状。